Methods and compositions for topical expression of rna for administration
By administering RNA molecules systemically and utilizing the endogenous mechanisms of monocytes and macrophages to express them at sites of acute inflammation, the treatment challenges of acute inflammation sites have been solved, achieving effective healing and functional recovery of heart and brain tissues.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BIONTECH SE
- Filing Date
- 2024-09-06
- Publication Date
- 2026-06-02
AI Technical Summary
Existing technologies struggle to effectively deliver proteins to sites of acute inflammation. Local administration is difficult to achieve, and systemic administration may lead to drug diffusion or immune reactions, making it ineffective in treating acute inflammation in the heart or brain.
By administering RNA molecules systemically, they are expressed at sites of acute inflammation. The RNA molecules are then delivered to the site of inflammation using endogenous mechanisms of monocytes and macrophages, encoding therapeutic proteins to promote tissue repair and functional recovery.
It achieves effective expression of RNA molecules at the site of acute inflammation, enhances healing and organ function, reduces the side effects of systemic administration, and improves treatment efficacy.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3